FDA is optimistic that an increase in “no objection” responses to new dietary ingredient notifications signals a positive trend, but has a more critical view of the industry's clarity about when the notifications are required and information they should contain.
FDA Waits For NDI Notifications Increase On Tail Of 'No Objection' Uptick
FDA has seen an uptick in “acknowledgement with no objection” response letters to dietary supplement firms' s NDI notifications, but says those positive responses still account for only a quarter of all its responses.